Nephrology Summit Market Analysis and Reports | Netherlands Conference Series

Market Analysis - Nephrology Summit 2018

Scope and Importance of Nephrology Research

Global burden of nephrology mortality is increasing drastically every year. According to WHO 10% of the population worldwide is affected by kidney diseases and approximately 65 million die each year. Kidney disease was ranked 16th in the list of causes of total number of deaths. Over 2 million people worldwide currently receive treatment with dialysis or a kidney transplant to stay alive. Of the 2 million people who receive treatment for kidney failure, the majority are treated in only five countries – the United States, Japan, Germany, Brazil, and Italy. Reflecting this imperative, we believe that professionally-oriented education in to cure Renal diseases is essential in the training of clinicians and clinical academics who will provide the future leadership in this key area for global health. Nephrology and Hypertension conferences aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nephrology. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Neonatology and Perinatology.

Members Associated with Nephrology Research

Nephrologists

Urologist

Pediatric Nephrology

Fellows or postdoctoral students

Nephrology academicians

Students pursuing an MD or PhD

Emeritus

Young research scientists

Business delegates

 

Hospitals Associated with Nephrology Research

Italy

Azienda Ospedaliero Universitaria Santa Maria della Misericordia

Giannina Gaslini Children's Hospital

Humanitas Gavazzeni

Azienda Ospedaliero-Universitaria Ospedale Cattinara

Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione

Europe

Klinik Hirslanden, Zurich

Klinik Im Park, Zurich

Health Centre Bad Ragaz

Klinik Pyramide Am See

Klinik Beau-Site, Berne

Hirslanden Clinique La Colline

Lucerne Health

Salem-Spital, Berne

Hirslanden Klinik Aarau

J.W. Goethe University Hospital

World

Mayo Clinic

Cleveland Clinic

New York-Presbyterian University Hospital of Columbia and Cornell

UCSF Medical Center

Brigham and Women's Hospital

Johns Hopkins Hospital

Massachusetts General Hospital

UCLA Medical Center

Duke University Hospital

Vanderbilt University Medical Center

 

Societies Associated with Nephrology Research

Italy

Italian Society of Nephrology

Europe

Danish Society of Nephrology

Swedish Society of Nephrology

British Association of Pediatric Nephrology

French Society of Nephrology

Polish Society of Nephrology

Albanian Society of Nephrology

Belgian Society of Nephrology

Austrian Society of Nephrology

German Society of Nephrology

The Renal Association (UK)

World

International Society of Nephrology (ISN) Gateway

American Society of Nephrology

The Philippine Society of Nephrology

Canadian society of nephrology

Kidney Disease Association‎

The National Kidney Foundation

Chronic Kidney Disease - World Kidney Day

Clinical Journal of the American Society of Nephrology

Indian society of nephrology

Renal association

The Asian Pacific Society of Nephrology

Emirates medical association on nephrology society

Industries Associated with Nephrology Research

Italy

Svenska Cellulosa Aktiebolaget SCA

Coloplast

Fresenius Medical Care AG & Co. KGaA

Baxter International Inc.

Hartmann Group

ONTEX International N.V.

First Quality Enterprises, Inc.

B. Braun Melsungen AG

Astra Tech Inc.

Kimberly-Clark Corporation

Covidien plc

Bellco Srl

C. R. Bard, Inc.

Siemens Healthcare

EDAP TMS S.A.

Bellco Srl

Europe

Biocon

Kaneka Pharma Company

NxStage Medical, Inc.

Storz Medical AG

Siemens Healthcare

EDAP TMS S.A

Dornier MedTech GmbH

Nikkiso CO., LTD.

Teleflex Incorporated

Medline Industries, Inc.

Asahi Kasei Corporation

World

Amgen

Astellas

Baxter International Inc.

DaVita HealthCare Partners Inc.

Amerisourcebergen

Genentech

Keryx Biopharmaceuticals, Inc.

Mallinckrodt Pharmaceuticals 

Anthem Biopharma

Sandor

Janssen Biotech,inc

 Universities Associated with Nephrology Research

Italy

Marche Polytechnic University

Università degli studi di Bari Aldo Moro

University of Bologna

University of Molise

University of Chieti

University of Ferrara

University of Foggia

Europe

University of Oxford

University of Cambridge

Imperial College London

University College London

University of Manchester

University of Barcelona

University of Glasgow

University of Oslo

World

Stanford University

University of Michigan

Yale school of medicine

University of Washington

University of Wisconsin

Budapest Nephrology School

Market Value on Nephrology Research

Netherlands

According to the recent statistics the 18th leading death cause of greece is kidney diseases. The morality rate in italy for kidney diseases is 5.47 In the world, every year at least 2.3 million people may have died because of kidney failure. The 9th leading cause of deaths in USA is kidney disease. It is being acknowledged that throughout USA more than 17,105 kidney transplantations took place in 2014 alone. In 2015, 11,570 came from deceased donors and 5,535 came from living donors. Every day 12 people die while waiting for a life-saving kidney transplant. For every 14 minutes an individual is added to the renal transplant list. In 2014, 4,270 patients died due to increasing the lag time for a kidney transplant. Another, 3,617 people became too sick to take delivery of kidney transplant

World

According to recent statistics report, nearly 26 million adults apart from young and old aged people are suffering from Chronic Kidney Disease complaints and millions of others are at increased risk. Medical Expenditures per patient per year with kidney disease increase from $15,000 in stage 3 to $28,000 in stage 4 to more than $70,000 in stage 5. Every year Medicare spent nearly $28.6 billion to treat people with kidney failure. National kidney Foundation has provided more than $100 million for research. Annually US spent $41 billion or 17% of their medicare budget on people with kidney diseases. The numbers of Kidney transplantations are seemingly very high and in the year of 2013 alone, there are around 15000 kidney transplantations. Being one of the major fields of Internal Medicine, Nephrological research received a funding of more than 5 billion dollars annually across the globe. Nearly $ 560 million is being funded on Kidney diseases alone per year due to the rapid increase for the risk of renal disorders.

Market Growth of Nephrology Research in the last and upcoming years

In 2011, the market value for nephrology at USD 13.3 billion, and it is expected to reach an estimated value of USD 20.5 billion in 2018, growing at a CAGR of 6.4% from 2012 to 2018. According to WHO, more than 190 million patients suffering from chronic renal failure undergo renal dialysis In 2011, total Medicare spending was $549.1 billion, and of that, costs for kidney failure were $34.3 billion, or 6.2% of the total Medicare budget. Annually US spent $41 billion or 17% of their medicare budget on people with kidney diseases. Approximately coming 5 years it is increased to $52 billion for kidney diseases Approximately 17,000 kidney transplants are performed annually, yet the American waiting list for lifesaving kidney transplants includes 95,000 individuals. 

 

Products manufactured by the industry

Global-2014

Auryxia (Ferric citrate); Keryx Biopharma

Harvoni (ledipasvir and sofosbuvir); Gilead

Viekira Pak (ombitasvir, paritaprevir, ritonavir and dasabuvir) tablets; Abbvie

2013

Procysbi (cysteamine bitartrate); Raptor Pharmaceuticals

Injectafer (ferric carboxymaltose injection); Luitpold Pharmaceuticals

2012

Afinitor (everolimus); Novartis

Inlyta (axitinib); Pfizer

Myrbetriq (mirabegron)

Omontys (peginesatide); Affymax

Stendra (avanafil); Vivus

Stivarga (regorafenib); Bayer HealthCare Pharmaceuticals

Voraxaze (glucarpidase); BTG International

2011

Anturol (oxybutynin) Gel; Antares Pharma

Nulojix (belatacept); Bristol-Myers Squibb

Soliris (eculizumab); Alexion

USA

Aranesp® — U.S

Sensipar® — U.S

Products-globally

Catheter Guidewires

Single Lumen Femoral Catheter

Haemodialysis Double Lumen Catheter

Haemodialysis Triple Lumen Catheter Kit

Haemodialysis Catheter Kit Double Lumen

Transducer Protector

Fistula Needle

Biopsy Needle Manual

Hand Control Pencil

Nitinol core wire

Dialysis Catheter

Disposable Fistula Needle

Pediatric Protector

Pediatric Transducer

Femoral Catheter

Haemodialysis Catheter

AV Fistula Needle

Biopsy Gun

Fund Allotment to Nephrology Research

World

 Feeding America- $1.86 billion- up 22.8% from a year earlier.

Salvation Army - $2.08 billion- year-to-year 10.3% increase

Predictive factors of long-term dysfunction and renal graft loss- 5.500 €- Source: Centro Hospitalar do Porto and UMIB/FCT

American Kidney Fund- $213 M

Europe

Simultaneous kidney-pancreas transplantation- 24.000 €- Source: Department of Nephrology from Centro Hospitalar do Porto

Nephropatic hereditary amyloidosis- Funding: 2.000 €- Source: Portuguese Society of Nephrology and Funding: 2.100 €. Source: UMIB/FCT

Uremia and functional-structural peritoneal membrane changes- Funding: 25.000 €. Source: Portuguese Society of Nephrology.

Spain

Salvation Army - $2.08 billion- year-to-year 10.3% increase

European Living Donor Psychosocial Follow-up- Funding: 1.4 €. 

Task Force for Global Health- $1.57 billion- 5.2% drop in donations.

Metabolic changes in peritoneal dialysis- Funding: 2.600 €. Source: UMIB/FCT.

 

Statistics of Physicians, Researchers and Academicians working on Nephrology

Europe

Academicians-2500

Students-28000

Physicians-17000

Total nephrologists-8567

 World

Academicians-16500

Students-1,25,075

Physicians-45,650

Total nephrologists-55,545